BioTime fails to receive a sufficient number of votes to approve the BioTime Share Issuance Proposal, BioTime may propose to adjourn
the BioTime Special Meeting, if a quorum is present, for a period of not more than 45 days for the purpose of soliciting additional
proxies to approve the BioTime Share Issuance Proposal. BioTime currently does not intend to propose adjournment at the BioTime
Special Meeting if there are sufficient votes to approve the BioTime Share Issuance Proposal.
Required; Recommendation of the BioTime Board
of the BioTime Adjournment Proposal requires the affirmative vote of a majority of the voting power of the shares present in person
or represented by proxy at the meeting and entitled to vote on the proposal. If you are a BioTime shareholder and fail to vote
or fail to instruct your broker or nominee to vote, it will have no effect on the BioTime Adjournment Proposal, assuming a quorum
is present; however, if you vote to abstain, it will have the same effect as a vote against the BioTime Adjournment Proposal.
BioTime Board recommends that BioTime shareholders vote “FOR” the BioTime Adjournment Proposal.